Antibiotic resistance is of growing concern to the medical community and is associated with substantial morbidity and mortality. Accordingly, beginning in 2012, the United States federal government incentivized the development of new antibiotics. A variety of new antimicrobials have been approved over the last decade that are becoming routinely used in clinical practice. In this session, we will address the clinical data supporting the use of these antibiotics in specific clinical scenarios and identify clinical pearls germane to the infusion nurse.

Learning Objectives: At the conclusion of this session, learners will be able to: 
• Describe the current landscape of antimicrobial development, approval, and use within the United States
• Explain mechanisms of antimicrobial resistance
• Identify newly approved antibiotics and their role in clinical care
• Appropriately monitor a patient receiving a novel antibiotic for therapeutic appropriateness and clinical success

CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

Contact Hours: This session has been approved for 1 contact hour

Expiration date for receipt of contact hours: November 12, 2028

To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.